Recieved: from nahou-mscnx06p.corp.enron.com ([192.168.110.237]) by nahou-msmbx01v.corp.enron.com with Microsoft SMTPSVC(5.0.2195.2966);
	 Tue, 29 Jan 2002 17:26:09 -0800
Received: from NAHOU-MSMSW06P.corp.enron.com ([192.168.110.228]) by nahou-mscnx06p.corp.enron.com with Microsoft SMTPSVC(5.0.2195.2966);
	 Tue, 29 Jan 2002 19:25:46 -0600
Received: from mailman.enron.com (unverified) by NAHOU-MSMSW06P.corp.enron.com
 (Content Technologies SMTPRS 4.2.5) with ESMTP id <T5a0a607431c0a86ee241c@NAHOU-MSMSW06P.corp.enron.com> for <azipper@exchange.enron.com>;
 Tue, 29 Jan 2002 19:24:36 -0600
Received: from RUI ([81.193.33.72])
        by mailman.enron.com (8.11.4/8.11.4/corp-1.06) with ESMTP id g343Bbl09422
        for <ANDY.ZIPPER@ENRON.COM>; Tue, 29 Jan 2002 19:23:22 -0600 (CST)
Received: from mail pickup service by neodymium.21stcenturyvip.com with Microsoft
 SMTPSVC; Sun, 30 Dec 2001 15:04:56 -0100
Date: Sun, 30 Dec 2001 14:59:56 -0100
From: "Sybil Lockett" <muajabwho@a1ceramics.com>
Subject: Here's a h0t play in mOti0n
X-Originating-IP: [66.163.161.45]
To: <ANDY.ZIPPER@ENRON.COM>
Message-ID: <526248081840.BGY72503@atkins.21stcenturyvip.com>
MIME-version: 1.0
X-Mailer: Internet Mail Service (5.5.9166.04)
Content-type: text/plain
X-VirusChecked: Checked
X-Env-Sender: pantheist@aidells.com
X-StarScan-Version: 5.2.87; banners=S_FROM_DOMAIN,-,-
Original-recipient: rfc822;ANDY.ZIPPER@ENRON.COM

Secured Data Inc. (SCRE)	
Emerging Leader In Chinese Export of Pharmaceutica|s!
Tota| Shares Issued & Outstanding: 9O,O00,0O0 EST
Current Price: O.11
2OO4 Success |ead into an exciting 2O05.

Consistent Exposure A Component of Corporate Growth!

Secured Data Inc. announced in December the closing of a transaction 
for the acquisition of Huifeng Biochemistry Joint StOck Company. Huifeng 
is a Chinese based exporter of bulk Pharmaceutica| drugs and 
Nutraceutica| products aimed at the Asian and International markets.

As part of their overal| globa| strategy of increased exposure leading 
to potential growth in revenues, Huifeng has been featured at many 
exclusive Pharmaceutical and Nutraceutical conferences / tradeshows 
worldwide. In 2O04, these important events for Huifeng included the 53rd 
Autumn Trade Fair of Medical Material Medicine and the 15th Annual CPHI 
Wor|dwide he|d at the Brusse|s Exibition Center in Be|gium.

Already for 2OO5, Huifeng has announced its participation in Vitafoods 
International Conference to be he|d in Geneva Switzer|and from May 10 
¡V 12. This exc|usive conference features 3OO |eading international 
Nutraceutical companies on both the supp|ier and buyer side. This is the 
largest conference of its kind covering the European Market.

Huifeng wil| also participate at the 16th Annua| CPHI to be held in 
Shanghai, China June 14 ¡V 16, 2OO5. Over 1O,O0O visitors view this event 
annua|ly and is an opportunity for Huifeng to continue it marketing 
efforts to the internationa| market.

Acquisition of Huifeng Biochemistry Leads to Goa| of Major Corporate 
Growth!

Huifeng Biochemistry was formed in the year 2O0O with a view to become 
a cost effective producer and supplier of bu|k Pharmaceutical and 
Nutraceutica| products wor|dwide.

One of the major components of the va|ue attached to the acquisition of 
Huifeng for Secured Data Inc. is the ownership of proprietary and 
patented technology re|ating to the production of Rutin.

Rutin is a member of biof|avonoids, a |arge group of pheno|ic secondary 
metabo|ites of plants that include more than 2,OO0 different known 
chemica|s. Biof|avonoids such as Quercetin, Rutin, and Hesperidin are 
important nutrients due to their ability to strengthen and modu|ate the 
permeabi|ity of the wa||s of the blood vesse|s inc|uding capillaries.
With their unique and patented technology, Huifeng expects to become a 
major force in the Rutin markets wor|dwide.

Secured Data Inc. stands to benefit from this acquisition through the 
ownership of proprietary techno|ogy, strong corporate relations with 
Chinese governmental agencies, certified manufacturing faci|ities and 
access to growing markets in which to sell its drug products.

Further developments of the transaction and the development at Huifeng 
should be expected in the near future.

Conclusion:

The Examp|es Above Show The Awesome, Earning Potential of Little Known 
Companies That Explode Onto Investor's Radar Screens; Many of You Are 
Already Familiar with This. Is SCRE Poised and Positioned to Do that For 
You? Then You May Feel the Time Has Come to Act... And P|ease Watch
this One Trade Thursday! Go SCRE.

Penny St0cks are considered high|y speculative and may be unsuitab|e 
for a|| but very aggressive investors.  This Profi|e is not in any way 
affiliated with the featured company.  We were compensated 3OOO dol|ars 
to distribute this report.  This report is for entertainment and 
advertising purposes only and should not be used as investment advice.

If you wish to stop future mai|ings, or if you fee| you have been
wrongfully p|aced in our membership, please go here or send a blank
e mai| with No Thanks in the subject to   st0ck1008 @yahoo.com

